Levitee Labs Inc
Levitee Labs Inc., a multidisciplinary integrative wellness company, provides evidence-based alternative medicines and novel psychedelic therapies. The company operates through two segments, Medical Services and Selling Products. It offers treatments and medications for substance use disorders and chronic pain, such as myofascial pain, fibromyalgia, neuropathy, and chronic regional pain syndrome,… Read more
Levitee Labs Inc (LVTTF) - Total Assets
Latest total assets as of June 2022: $12.54 Million USD
Based on the latest financial reports, Levitee Labs Inc (LVTTF) holds total assets worth $12.54 Million USD as of June 2022.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Levitee Labs Inc - Total Assets Trend (2019–2021)
This chart illustrates how Levitee Labs Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Levitee Labs Inc - Asset Composition Analysis
Current Asset Composition (September 2021)
Levitee Labs Inc's total assets of $12.54 Million consist of 21.5% current assets and 78.5% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 5.4% |
| Accounts Receivable | $530.31K | 4.1% |
| Inventory | $1.19 Million | 9.1% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $3.66 Million | 28.3% |
| Goodwill | $4.05 Million | 31.3% |
Asset Composition Trend (2019–2021)
This chart illustrates how Levitee Labs Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Levitee Labs Inc's current assets represent 21.5% of total assets in 2021, a decrease from 100.0% in 2019.
- Cash Position: Cash and equivalents constituted 5.4% of total assets in 2021, down from 83.5% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 59.0% of total assets, an increase from 0.0% in 2019.
- Asset Diversification: The largest asset category is goodwill at 31.3% of total assets.
Levitee Labs Inc Competitors by Total Assets
Key competitors of Levitee Labs Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Levitee Labs Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Levitee Labs Inc generates 0.13x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Levitee Labs Inc is currently not profitable relative to its asset base.
Levitee Labs Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.45 | 7.90 | 61.04 |
| Quick Ratio | 0.22 | 7.86 | 61.04 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-3.19 Million | $ 9.92 Million | $ 154.42K |
Levitee Labs Inc - Advanced Valuation Insights
This section examines the relationship between Levitee Labs Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.06 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 8158.7% |
| Total Assets | $12.97 Million |
| Market Capitalization | $24.97 USD |
Valuation Analysis
Below Book Valuation: The market values Levitee Labs Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Levitee Labs Inc's assets grew by 8158.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Levitee Labs Inc (2019–2021)
The table below shows the annual total assets of Levitee Labs Inc from 2019 to 2021.
| Year | Total Assets | Change |
|---|---|---|
| 2021-09-30 | $12.97 Million | +8158.73% |
| 2020-09-30 | $156.99K | -56.07% |
| 2019-09-30 | $357.34K | -- |